Immunophenotype of High-Grade Prostatic Adenocarcinoma and Urothelial Carcinoma (original) (raw)

Prostate cancer immunology - an update for Urologists

Damien Bolton

BJU International, 2011

View PDFchevron_right

Molecular pathology of prostate cancer

Angelo Marzo

Journal of Clinical Pathology, 2005

View PDFchevron_right

Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the Prostate

David Ellis

American Journal of Clinical Pathology, 1984

View PDFchevron_right

Molecular alterations associated with prostate cancer

adalberto sanchez gomez

Central European Journal of Urology, 2018

View PDFchevron_right

Study of serum prostate specific antigen levels in patients with prostate lesions

DrashtI Shukla

International Journal of Clinical and Diagnostic Pathology, 2021

View PDFchevron_right

Molecular genetics of prostate cancer

adnan albadran

Annals of Medicine, 2001

View PDFchevron_right

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Scott Lucia

The New England Journal of Medicine, 2004

View PDFchevron_right

Five Genetic Variants Associated with Prostate Cancer

Wayne Hall

New England Journal of Medicine, 2008

View PDFchevron_right

New concepts in the pathology of prostatic epithelial carcinogenesis

Angelo Marzo

Urology, 2001

View PDFchevron_right

Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?

T. Roskams

Prostate Cancer and Prostatic Diseases, 2003

View PDFchevron_right

Benign mimics of prostatic adenocarcinoma

Kiril Trpkov

Modern Pathology, 2018

View PDFchevron_right

Cancer testis antigens

Archana verma

OncoImmunology, 2012

View PDFchevron_right

Prostate Cancer, Version 2.2014

Mack Roach

Journal of the National Comprehensive Cancer Network, 2014

View PDFchevron_right

Urinary Tract Large Cell Neuroendocrine Carcinoma

Alessia Cimadamore

Encyclopedia of Pathology, 2020

View PDFchevron_right

Increased Cumulative Incidence of Prostate Malignancies in Colorectal Cancer Patients

Nuri Ozden

International Journal of Gastrointestinal Cancer, 2004

View PDFchevron_right

Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract

Markku Seppälä

Cancer, 1975

View PDFchevron_right

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

Bernard Candas

Urology, 1996

View PDFchevron_right

Carcinoma of the prostate: Clinical and pathological staging and prognosis

Jack Elder

The Prostate, 1983

View PDFchevron_right

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer

Bernard Candas

The Prostate, 2000

View PDFchevron_right

Focus on prostate cancer

Angelo Marzo

Cancer Cell, 2002

View PDFchevron_right

Correlation of serum prostate-specific antigen level in various prostate pathology in elderly men

Dr.varsha Khant

International Journal of Medical Science and Public Health, 2017

View PDFchevron_right

Early Human Prostate Adenocarcinomas Harbor Androgen-Independent Cancer Cells

Rita Fiñones

PLoS ONE, 2013

View PDFchevron_right

Pattern of cancer/testis antigen expression in lung cancer patients

Yeong Hyeock Kim

International Journal of Molecular Medicine, 2012

View PDFchevron_right

Normal Development and Carcinogenesis of the Prostate

Gerald Cunha

Annals of the New York Academy of Sciences, 1996

View PDFchevron_right

Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL

Javier Hernandez

Urology, 2007

View PDFchevron_right

Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma

Ylermi Soini

Histopathology, 1994

View PDFchevron_right

Value of percent free prostate-specific antigen for the prediction of pathological stage in men with clinically localized prostate cancer

Enrique Trilla

The International Journal of Biological Markers, 2002

View PDFchevron_right

Epidemiologic determinants of clinically relevant prostate cancer

Thomas Wheeler

International Journal of Cancer, 2000

View PDFchevron_right

An Analysis of Patients with Clinically Localized High-Risk Prostate Carcinoma

Mack Roach

The Prostate Journal, 2000

View PDFchevron_right

Colorectal cancer-associated nuclear antigen

Wanda Krajewska

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000

View PDFchevron_right

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets

Angelo Marzo

Advances in Anatomic Pathology, 2008

View PDFchevron_right

Identification of Clinically Significant Prostate Cancer by Prostate-Specific Antigen Screening

Bruce Malkowicz

Archives of Internal Medicine, 2004

View PDFchevron_right

Co-occurrence of Dermatomyositis and Polycythemia Unveiling Rare de Novo Neuroendocrine Prostate Tumor

Stavros Giannopoulos

Frontiers in Oncology, 2018

View PDFchevron_right

A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate

Salvatore Giordano

International Urology and Nephrology, 2010

View PDFchevron_right

1664: Pathological Assessment of High Grade Tumors in the Prostate Cancer Prevention Trial (PCPT)

Scott Lucia

The Journal of Urology, 2005

View PDFchevron_right